BNTC (Benitec Biopharma) Institutional Ownership: 97.71% (As of Jul. 08, 2026)


BNTC Benitec Biopharma Inc BNTC
34 GF Score
Price $13.05
View Full Analysis

What is Benitec Biopharma Institutional Ownership?

Benitec Biopharma BNTC -2.90% 34 Institutional Ownership is 97.71% as of Jul. 08, 2026. GuruFocus rates BNTC with a GF Score™ of 34/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Benitec Biopharma's institutional ownership is 97.71%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Benitec Biopharma's Insider Ownership is 0.33%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Benitec Biopharma's Float Percentage Of Total Shares Outstanding is 56.51%.

Benitec Biopharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Benitec Biopharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benitec Biopharma Institutional Ownership Chart

Benitec Biopharma Historical Data

The historical data trend for Benitec Biopharma can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 26.50 25.07 20.46 20.46 20.68 22.14 23.84 24.20 24.30 25.88
BNTC
34GF Score
Benitec Biopharma Inc BNTC
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Benitec Biopharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 97.71% mean?
Benitec Biopharma (BNTC) has a Institutional Ownership of 97.71% as of Jul. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Benitec Biopharma and its competitors.
Is Benitec Biopharma's Institutional Ownership too high?
Benitec Biopharma's current Institutional Ownership is 97.71%. Overall, Benitec Biopharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Benitec Biopharma's Institutional Ownership compare to IPSC and FBRX?
Benitec Biopharma's Institutional Ownership of 97.71% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Benitec Biopharma and its competitors. Benitec Biopharma's current Institutional Ownership is 97.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Benitec Biopharma stock overvalued right now?
Benitec Biopharma (BNTC) has a current Institutional Ownership of 97.71%. The current Institutional Ownership is 97.71%. Benitec Biopharma's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Benitec Biopharma (BNTC), the current Institutional Ownership is 97.71% as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Benitec Biopharma Business Description

Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
34GF Score

Get the complete analysis for BNTC

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.05
Price